A detailed history of Wealth Management Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Management Partners, LLC holds 3,853 shares of ABBV stock, worth $681,788. This represents 0.36% of its overall portfolio holdings.

Number of Shares
3,853
Previous 4,342 11.26%
Holding current value
$681,788
Previous $744,000 2.15%
% of portfolio
0.36%
Previous 0.37%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$163.84 - $199.33 $80,117 - $97,472
-489 Reduced 11.26%
3,853 $760,000
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.02%
4,342 $744,000
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $58,174 - $66,284
-364 Reduced 7.74%
4,341 $790,000
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $90,678 - $102,125
-659 Reduced 12.29%
4,705 $729,000
Q3 2023

Oct 24, 2023

SELL
$133.59 - $154.65 $24,981 - $28,919
-187 Reduced 3.37%
5,364 $799,000
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $8,878 - $11,048
-67 Reduced 1.19%
5,551 $747,000
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $89,368 - $102,921
618 Added 12.36%
5,618 $895,000
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $134,210 - $153,930
1,000 Added 25.0%
5,000 $631,000
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $73,052 - $92,432
680 Added 20.48%
4,000 $540,000
Q3 2021

Oct 29, 2021

SELL
$106.4 - $120.78 $2,128 - $2,415
-20 Reduced 0.6%
3,320 $358,000
Q2 2021

Jul 14, 2021

BUY
$105.21 - $117.21 $5,365 - $5,977
51 Added 1.55%
3,340 $376,000
Q1 2021

Apr 15, 2021

BUY
$102.3 - $112.62 $56,469 - $62,166
552 Added 20.17%
3,289 $346,000
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $220,301 - $297,429
2,737 New
2,737 $298,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealth Management Partners, LLC Portfolio

Follow Wealth Management Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Management Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Management Partners, LLC with notifications on news.